Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Rationale: There is a need to minimize oral corticosteroid (OCS) use in patients with asthma to prevent their costly and burdensome adverse effects. Current guidelines do not provide recommendations for OCS tapering in patients with asthma. Objectives: To develop expert consensus on OCS tapering among international experts. Methods: A modified Delphi method was used to develop expert consensus statements relating to OCS use, tapering, adverse effects, adrenal insufficiency, and patient–physician shared decision-making. Initial statements proposed by experts were categorized, filtered for repetition, and presented back to experts over three ranking rounds to obtain consensus (≥70% agreement). Measurements and Main Results: One hundred thirty-one international experts participated in the study, and 296 statements were ranked. Numerous recommendations and guidance regarding appropriate OCS use were established. Experts agreed that OCS tapering should be attempted in all patients with asthma receiving maintenance OCS therapy, with personalization of tapering rhythm and speed. The importance of recognizing individual adverse effects was also established; however, a unified approach to the assessment of adrenal insufficiency was not reached. Shared decision-making was considered an important goal during the tapering process. Conclusions: In this Delphi study, expert consensus statements were generated on OCS use, tapering, adverse-effect screening, and shared decision-making, which may be used to inform clinical practice. Areas of nonconsensus were identified, highlighting uncertainty among the experts around some aspects of OCS use in asthma, such as adrenal insufficiency, which underscores the need for further research in these domains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a morning serum cortisol level can also identify adrenal insufficiency, 18 followed by an ACTH stimulation test if results are indeterminate 19,20”
From Home waking salivary cortisone to screen for adrenal insufficiency (2023) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
PAUWELS, R. A. (1996) · Arerugī/Arerugi · doi:10.15036/arerugi.45.792 · Cited by 9,994
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Chung, K. F., Wenzel, S. E., Brozek, J. L., Bush, A., Castro, M., Sterk, P. J., Adcock, I. M., Bateman, E. D., Bel, E. H., Bleecker, E. R., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00202013 · Cited by 3,926 · cited 1×
“Approximately 5–10% of the overall asthma population have severe asthma (3), defined as uncontrolled asthma despite adherence to maximal optimized therapy and treatment of contributory factors (4).”
BackgroundSelf-citationAsthma exacerbations and sputum eosinophil counts: a randomised controlled trial
Green, R. H., Brightling, C. E., McKenna, S., Hargadon, B., Parker, D., Bradding, P., Wardlaw, A. J., & Pavord, I. D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11679-5 · Cited by 1,755
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
Bel, E. H., Wenzel, S. E., Thompson, P. J., Prazma, C. M., Keene, O. N., Yancey, S. W., Ortega, H. G., & Pavord, I. D. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403291 · Cited by 1,661
Liu, D., Ahmet, A., Ward, L., Krishnamoorthy, P., Mandelcorn, E. D., Leigh, R., Brown, J. P., Cohen, A., & Kim, H. (2013) · Allergy, Asthma & Clinical Immunology · doi:10.1186/1710-1492-9-30 · Cited by 1,268
Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma
Nair, P., Wenzel, S., Rabe, K. F., Bourdin, A., Lugogo, N. L., Kuna, P., Barker, P., Sproule, S., Ponnarambil, S., & Goldman, M. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1703501 · Cited by 1,044
Self-citationWaljee, A. K., Rogers, M. A. M., Lin, P., Singal, A. G., Stein, J. D., Marks, R. M., Ayanian, J. Z., & Nallamothu, B. K. (2017) · BMJ · doi:10.1136/bmj.j1415 · Cited by 830 · cited 1×
“approximately 6-days in a large database study, is associated with an increase in sepsis, venous thromboembolism, and fracture in the next 30 days (36).”
BackgroundTreatment of Allergic Asthma with Monoclonal Anti-IgE Antibody
Milgrom, H., Fick, R. B., Su, J. Q., Reimann, J. D., Bush, R. K., Watrous, M. L., & Metzger, W. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912233412603 · Cited by 704
Holgate, S. T., Wenzel, S., Postma, D. S., Weiss, S. T., Renz, H., & Sly, P. D. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.25 · Cited by 652
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations
Jayaram, L., Pizzichini, M. M., Cook, R. J., Boulet, L.-P., Lemière, C., Pizzichini, E., Cartier, A., Hussack, P., Goldsmith, C. H., Laviolette, M., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00137704 · Cited by 603
Cited by
Biologics and airway remodeling in severe asthma
Varricchi, G., Ferri, S., Pepys, J., Poto, R., Spadaro, G., Nappi, E., Paoletti, G., Virchow, J. C., Heffler, E., & Canonica, W. G. (2022) · Allergy · doi:10.1111/all.15473 · Cited by 254
Self-citationMenzies-Gow, A., Gurnell, M., Heaney, L. G., Corren, J., Bel, E. H., Maspero, J., Harrison, T., Jackson, D. J., Price, D., Lugogo, N., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00352-0 · Cited by 177
Self-citationMenzies-Gow, A. N., Hoyte, F. C. L., Price, D. B., Cohen, D., Barker, P. N., Kreindler, J. L., Jison, M. L., Brooks, C. L., Papeleu, P., & Katial, R. K. (2022) · Advances in Therapy · doi:10.1007/s12325-022-02098-1 · Cited by 165
Self-citationGEMA 5.3. Spanish Guideline on the Management of Asthma
Plaza, V., Alobid, I., Rodríguez, C. Á., Blanco‐Aparicio, M., Ferreira, J., García, G., Gómez‐Outes, A., Garín, N., Ruiz, F. G., Requena, A. H., et al. (2023) · Open Respiratory Archives · doi:10.1016/j.opresp.2023.100277 · Cited by 132
Blakey, J., Chung, L. P., McDonald, V. M., Ruane, L. E., Gornall, J., Barton, C., Bosnic-Anticevich, S. Z., Harrington, J., Hew, M. J., Holland, A. E., et al. (2021) · Respirology · doi:10.1111/resp.14147 · Cited by 114
Metadata
- Authors
- Suehs, C. M., Menzies-Gow, A., Price, D., Bleecker, E. R., Canonica, G. W., Gurnell, M., & Bourdin, A.
- Affiliations
- Département des Maladies Respiratoires and
- Centre National de la Recherche Scientifique (FR)
- National Health Service (GB)
- University of Aberdeen (GB)
- Humanitas University (IT)
- University of Cambridge (GB)
- Corresponding author
- Suehs, Carey M.
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-04-01
- Volume
- 203
- Issue
- 7
- Pages
- 871-881
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W3097151762
- Cited by
- 118
- References
- 43
- Citations by year
- 2026: 7 · 2025: 22 · 2024: 22 · 2023: 21 · 2022: 30 · 2021: 13
- FWCI
- 9.77
- Type
- journal article
- Language
- en
- Open access
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Repository@Hull (Worktribe) (University of Hull) (submittedVersion, cc-by)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- Apollo (University of Cambridge) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Aberdeen University Research Archive (Aberdeen University) (submittedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- ORBi (University of Liège) (submittedVersion)
- Apollo
- Funders
- AstraZeneca
- National Institute for Health and Care Research (PB-PG-1217-20007)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- asthma, oral corticosteroids, corticosteroid tapering, adrenal insufficiency, corticosteroid adverse effects, shared decision-making, clinical guidelines
- MeSH terms
- Administration, Oral, Adrenal Cortex Hormones, Adult, Asthma, Delphi Technique, Drug Administration Schedule, Expert Testimony, Female, Humans, Male, Middle Aged, Practice Guidelines as Topic, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study. https://app.cochat.ai/papers/10.1164/rccm.202007-2721oc
- The paper
- Suehs, C. M., Menzies-Gow, A., Price, D., Bleecker, E. R., Canonica, G. W., Gurnell, M., & Bourdin, A. (2021). Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.202007-2721oc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.